LDLR anticorps (AA 391-419)
-
- Antigène Voir toutes LDLR Anticorps
- LDLR (Low Density Lipoprotein Receptor (LDLR))
-
Épitope
- AA 391-419
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LDLR est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Specificité
- This LDLR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 391-419 amino acids from the Central region of human LDLR.
- Purification
- Affinity purified
- Isotype
- IgG
- Top Product
- Discover our top product LDLR Anticorps primaire
-
-
- Indications d'application
- Approved: ELISA (1:1000), WB (1:100 - 1:500)
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, 0.09 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
- Antigène
- LDLR (Low Density Lipoprotein Receptor (LDLR))
- Autre désignation
- LDLR / LDL Receptor (LDLR Produits)
- Synonymes
- anticorps FH, anticorps FHC, anticorps LDLCQ2, anticorps Hlb301, anticorps LDLRA, anticorps LDLA, anticorps LDL receptor-2, anticorps fhc, anticorps ldlcq2, anticorps ldlr, anticorps ldlr2-a, anticorps LDL receptor 1, anticorps ldlr-a, anticorps ldlr-b, anticorps low density lipoprotein receptor, anticorps low density lipoprotein receptor a, anticorps low density lipoprotein receptor S homeolog, anticorps low density lipoprotein receptor L homeolog, anticorps LDLR, anticorps Ldlr, anticorps ldlra, anticorps ldlr.S, anticorps ldlr.L
- Sujet
-
Name/Gene ID: LDLR
Synonyms: LDLR, FHC, LDL receptor, LDLCQ2 - ID gène
- 3949
- Pathways
- Hepatitis C, Lipid Metabolism
-